LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Taxol
0.31623
 87.14 771.67 58 12592 0.0046 -0.4740
MN20160304_L01
M21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 2.49 771.67 814 867 0.9381 0.3709
MN20160304_L01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 2.49 771.67 980 867 1.1294 3.1029
MN20160304_L01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 2.49 771.67 907 867 1.0452 1.5973
MN20160304_L01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 2.49 771.67 799 867 0.9208 0.2283
MN20160304_L01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 4.71 771.67 931 956 0.9735 0.8336
MN20160304_L01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 4.71 771.67 1091 956 1.1408 2.0604
MN20160304_L01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 4.71 771.67 1024 956 1.0707 1.4939
MN20160304_L01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 4.71 771.67 883 956 0.9233 0.5454
MN20160304_L01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 6.94 771.67 991 1045 0.9482 0.7712
MN20160304_L01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 6.94 771.67 1223 1045 1.1702 1.8642
MN20160304_L01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 6.94 771.67 1130 1045 1.0812 1.3907
MN20160304_L01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 6.94 771.67 932 1045 0.8918 0.5394
MN20160304_L01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 9.16 771.67 1098 1138 0.9644 0.8750
MN20160304_L01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 9.16 771.67 1301 1138 1.1427 1.5369
MN20160304_L01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 9.16 771.67 1191 1138 1.0461 1.1673
MN20160304_L01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 9.16 771.67 1020 1138 0.8959 0.6442
MN20160304_L01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 11.56 771.67 1226 1280 0.9574 0.8842
MN20160304_L01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 11.56 771.67 1438 1280 1.1229 1.3437
MN20160304_L01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 11.56 771.67 1343 1280 1.0487 1.1345
MN20160304_L01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 11.56 771.67 1156 1280 0.9027 0.7386
MN20160304_L01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
 13.78 771.67 1395 1459 0.9556 0.9037
MN20160304_L01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
 13.78 771.67 1620 1459 1.1098 1.2398
MN20160304_L01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
 13.78 771.67 1487 1459 1.0187 1.0406
MN20160304_L01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
 13.78 771.67 1277 1459 0.8748 0.7293
MN20160304_L01
N21